Literature DB >> 47369

A hemolytic plaque assay for the detection of direct and indirect antibody-forming cells to keyhole limpet hemocyanin.

H B Herscowitz, R C Diblasio, J B Rosenberg.   

Abstract

A procedure is described for the in vitro enumeration of individual lymphoid cells producing antibody against Keyhole Limpet Hemocyanin (KLH) by a modification of the hemolytic plaque technique. Optimal conditions for the coupling of KLH to sheep erythrocytes by chromic chloride are described. Plaque-forming cells are detected in a liquid monolayer slide chamber assay system. The kinetics of the in vivo primary and secondary PFC responses of both rabbit popliteal lymph node cells and mouse spleen cells are described. Both direct (IgM) and indirect (IgG) plaque-forming cells can be enumerated. The method can also be used to detect an in vitro anamnestic response in dispersed rabbit lymph node cell suspensions. The method is simple, extremely sensitive and the results correlate with those previously obtained in which newly synthesized antibody was detected in similar systems using the coprecipitation assay.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 47369     DOI: 10.1016/0022-1759(75)90004-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Suppression of the primary immune response to keyhole limpet haemocyanin by antimacrophage globulin.

Authors:  H B Herscowitz; R C Diblasio
Journal:  Immunology       Date:  1976-01       Impact factor: 7.397

2.  Distribution and characterization of rhogocyte cell types in the mantle tissue of Haliotis laevigata.

Authors:  Fareed Sairi; Peter Valtchev; Vincent G Gomes; Fariba Dehghani
Journal:  Mar Biotechnol (NY)       Date:  2014-11-11       Impact factor: 3.619

3.  T cell-dependent immune response in C1q-deficient mice: defective interferon gamma production by antigen-specific T cells.

Authors:  A J Cutler; M Botto; D van Essen; R Rivi; K A Davies; D Gray; M J Walport
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.